Long-term Surveillance Registry for Biologics (HUMIRA).
Phase of Trial: Phase IV
Latest Information Update: 13 Jun 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms HUMIRA
- Sponsors Abbott Laboratories; AbbVie
- 07 Jun 2017 Biomarkers information updated
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Planned number of patients changed from 5738 to 5742.